Bluebird Bio Inc (BLUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 66,478 | 81,499 | 106,260 | 161,160 | 402,461 |
| Marketable Securities | 73,155 | 51,010 | 105,328 | 138,343 | 375,140 |
| Receivables | N/A | N/A | N/A | 11,389 | 23,246 |
| Inventories | N/A | N/A | N/A | N/A | 766 |
| Other current assets | 12,535 | 10,476 | 11,531 | 0 | 0 |
| TOTAL | $160,438 | $167,458 | $254,917 | $336,520 | $832,325 |
| Non-Current Assets | |||||
| PPE Net | 11,535 | 14,566 | 11,234 | 9,706 | 45,745 |
| Investments And Advances | 1,407 | 40,641 | 55,049 | 97,114 | 193,129 |
| Intangibles | 5,646 | 5,646 | 5,646 | 5,646 | 23,065 |
| Other Non-Current Assets | 341,072 | 345,281 | 164,225 | 144,809 | 245,380 |
| TOTAL | $359,660 | $406,134 | $236,154 | $257,275 | $507,319 |
| Total Assets | $520,098 | $573,592 | $491,071 | $593,795 | $1,339,644 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 18,622 | 24,865 | 28,350 | 25,883 | 21,668 |
| Accrued Expenses | 64,314 | 75,550 | 89,032 | 103,958 | 203,790 |
| Other current liabilities | N/A | N/A | N/A | N/A | 9,130 |
| TOTAL | $126,727 | $148,861 | $142,892 | $152,993 | $266,559 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 2,530 |
| Other Non-Current Liabilities | 234,514 | 244,615 | 84,920 | 66,525 | 176,797 |
| TOTAL | $234,514 | $244,615 | $84,920 | $66,525 | $202,558 |
| Total Liabilities | $361,241 | $393,476 | $227,812 | $219,518 | $469,117 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,145 | 3,856 | 3,573 | 3,572 | 3,505 |
| Common Shares | 829 | 735 | 714 | 711 | 701 |
| Retained earnings | -4,018,735 | -3,942,215 | -3,842,077 | -3,719,925 | -3,564,873 |
| Other shareholders' equity | -4,630 | -4,416 | -4,459 | -2,911 | -5,906 |
| TOTAL | $158,857 | $180,116 | $263,259 | $374,277 | $870,527 |
| Total Liabilities And Equity | $520,098 | $573,592 | $491,071 | $593,795 | $1,339,644 |